Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Links

Contact
About
Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MET Gene Alterations”

4 trials

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Showing 4 of 4 results

Large-scale testing (Phase 3)Looking for participantsNCT05722886

What this trial is testing

DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol

Who this might be right for

Haematological MalignancySolid Tumour

Cancer Research UK 825

Large-scale testing (Phase 3)Looking for participantsNCT06439225

What this trial is testing

Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

Who this might be right for

Metastatic Castration-resistant Prostate CancerMetastatic Prostate Cancer

Canadian Cancer Trials Group 236

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06885840

What this trial is testing

Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.

Who this might be right for

Non-Small Cell Lung Cancer

Betta Pharmaceuticals Co., Ltd. 100

Early research (Phase 1)Active Not RecruitingNCT03993873

What this trial is testing

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

Who this might be right for

Advanced Solid TumorMetastatic Solid TumorsMET Gene Alterations

Turning Point Therapeutics, Inc. 95